A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Clinical Trials, High Risk Prostate Cancer, Intermediate Risk Prostate Cancer

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05794906
Phase: Phase 3
Trial Summary: Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer. BCR means that in men who had prostate cancer and were treated by either surgery – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Bayer
Acronym: ARASTEP

Pin It on Pinterest